2020. Effectiveness and tolerability of early initiation of combined lipid-lowering therapy included simvastatin and fenofibrate vs simvastatin alone in patients with acute coronary syndrome and type 2 diabetes mellitus with hypertriglyceridemia. Ukrainian Journal of Cardiology. 27, 2 (Jun. 2020), 34–45. DOI:https://doi.org/10.31928/1608-635X-2020.2.3445.